Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5.

Lee YS, Lee DH, Jeong SY, Park SH, Oh SC, Park YS, Yu J, Choudry HA, Bartlett DL, Lee YJ.

J Cell Biochem. 2019 Jan;120(1):928-939. doi: 10.1002/jcb.27456. Epub 2018 Aug 30.

PMID:
30160785
2.

Correction: Molecular crosstalk between ferroptosis and apoptosis: Emerging role of ER stress-induced p53-independent PUMA expression.

Hong SH, Lee DH, Lee YS, Jo MJ, Jeong YA, Kwon WT, Choudry HA, Bartlett DL, Lee YJ.

Oncotarget. 2018 May 15;9(37):24869. doi: 10.18632/oncotarget.25365. eCollection 2018 May 15.

3.

Management of Mucinous Appendiceal Tumors.

Choudry HA, Pai RK.

Ann Surg Oncol. 2018 Aug;25(8):2135-2144. doi: 10.1245/s10434-018-6488-4. Epub 2018 May 1. No abstract available.

PMID:
29717422
4.

Crosstalk Between Apoptosis and Autophagy Is Regulated by the Arginylated BiP/Beclin-1/p62 Complex.

Song X, Lee DH, Dilly AK, Lee YS, Choudry HA, Kwon YT, Bartlett DL, Lee YJ.

Mol Cancer Res. 2018 Jul;16(7):1077-1091. doi: 10.1158/1541-7786.MCR-17-0685. Epub 2018 Apr 18.

PMID:
29669822
5.

Ferroptosis-Induced Endoplasmic Reticulum Stress: Cross-talk between Ferroptosis and Apoptosis.

Lee YS, Lee DH, Choudry HA, Bartlett DL, Lee YJ.

Mol Cancer Res. 2018 Jul;16(7):1073-1076. doi: 10.1158/1541-7786.MCR-18-0055. Epub 2018 Mar 28. Review.

PMID:
29592897
6.

Molecular crosstalk between ferroptosis and apoptosis: emerging role of ER stress-induced p53-independent PUMA expression.

Hong SH, Lee DH, Lee YS, Jo MJ, Jeong YA, Kwon WT, Choudry HA, Bartlett DL, Lee YJ.

Oncotarget. 2017 Dec 8;8(70):115164-115178. doi: 10.18632/oncotarget.23046. eCollection 2017 Dec 29. Erratum in: Oncotarget. 2018 May 15;9(37):24869.

7.

Targeting G-protein coupled receptor-related signaling pathway in a murine xenograft model of appendiceal pseudomyxoma peritonei.

Dilly AK, Honick BD, Lee YJ, Guo ZS, Zeh HJ, Bartlett DL, Choudry HA.

Oncotarget. 2017 Nov 6;8(63):106888-106900. doi: 10.18632/oncotarget.22455. eCollection 2017 Dec 5.

8.

Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei.

Choudry HA, Pai RK, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL.

Ann Surg Oncol. 2018 Jan;25(1):76-82. doi: 10.1245/s10434-017-6214-7. Epub 2017 Nov 6.

PMID:
29110275
9.

Safety and efficacy of combined resection of colorectal peritoneal and liver metastases.

Downs-Canner S, Shuai Y, Ramalingam L, Pingpank JF, Holtzman MP, Zeh HJ, Bartlett DL, Choudry HA.

J Surg Res. 2017 Nov;219:194-201. doi: 10.1016/j.jss.2017.05.126. Epub 2017 Jun 29.

10.

Institutional Experience with Ostomies Created During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion.

Pakraftar S, Ramalingam L, Shuai Y, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2017 Dec;24(13):3811-3817. doi: 10.1245/s10434-017-6114-x. Epub 2017 Oct 10.

PMID:
29019111
11.

Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer.

Magge D, Ramalingam L, Shuai Y, Edwards RP, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL, Choudry HA.

J Surg Oncol. 2017 Sep;116(3):320-328. doi: 10.1002/jso.24666. Epub 2017 Jun 19.

12.

Impact of genomic profiling on the treatment and outcomes of patients with advanced gastrointestinal malignancies.

Dhir M, Choudry HA, Holtzman MP, Pingpank JF, Ahrendt SA, Zureikat AH, Hogg ME, Bartlett DL, Zeh HJ, Singhi AD, Bahary N.

Cancer Med. 2017 Jan;6(1):195-206. doi: 10.1002/cam4.992. Epub 2016 Dec 28.

13.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases.

Dhir M, Ramalingam L, Shuai Y, Pakrafter S, Jones HL, Hogg ME, Zureikat AH, Holtzman MP, Ahrendt SA, Bahary N, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2017 Apr;24(4):875-883. doi: 10.1245/s10434-016-5689-y. Epub 2016 Dec 19.

PMID:
27995449
14.

Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids.

Radomski M, Pai RK, Shuai Y, Ramalingam L, Jones H, Holtzman MP, Ahrendt SA, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2016 Dec;23(13):4338-4343. Epub 2016 Jul 11.

PMID:
27401448
15.

Robotic assisted placement of hepatic artery infusion pump is a safe and feasible approach.

Dhir M, Zenati MS, Padussis JC, Jones HL, Perkins S, Clifford AK, Steve J, Hogg ME, Choudry HA, Holtzman MP, Zeh HJ 3rd, Pingpank JF, Bartlett DL, Zureikat AH.

J Surg Oncol. 2016 Sep;114(3):342-7. doi: 10.1002/jso.24325. Epub 2016 Aug 16.

PMID:
27529576
16.

Oncologic Risk Stratification Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Carcinomatosis.

Wagner PL, Austin F, Zenati M, Jaech A, Mavanur A, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2016 May;23(5):1587-93. doi: 10.1245/s10434-015-5037-7. Epub 2016 Jan 7.

PMID:
26744106
17.

Targeting hypoxia-mediated mucin 2 production as a therapeutic strategy for mucinous tumors.

Dilly AK, Lee YJ, Zeh HJ, Guo ZS, Bartlett DL, Choudry HA.

Transl Res. 2016 Mar;169:19-30.e1. doi: 10.1016/j.trsl.2015.10.006. Epub 2015 Oct 31.

PMID:
26589109
18.

The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.

Singhi AD, Krasinskas AM, Choudry HA, Bartlett DL, Pingpank JF, Zeh HJ, Luvison A, Fuhrer K, Bahary N, Seethala RR, Dacic S.

Mod Pathol. 2016 Jan;29(1):14-24. doi: 10.1038/modpathol.2015.121. Epub 2015 Oct 23.

19.

Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms.

Polanco PM, Ding Y, Knox JM, Ramalingam L, Jones H, Hogg ME, Zureikat AH, Holtzman MP, Pingpank J, Ahrendt S, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2016 Feb;23(2):382-90. doi: 10.1245/s10434-015-4838-z. Epub 2015 Oct 1.

PMID:
26429720
20.

Hypoxia Promotes Synergy between Mitomycin C and Bortezomib through a Coordinated Process of Bcl-xL Phosphorylation and Mitochondrial Translocation of p53.

Song X, Dilly AK, Choudry HA, Bartlett DL, Kwon YT, Lee YJ.

Mol Cancer Res. 2015 Dec;13(12):1533-43. doi: 10.1158/1541-7786.MCR-15-0237. Epub 2015 Sep 9.

21.

The learning curve for robotic distal pancreatectomy: an analysis of outcomes of the first 100 consecutive cases at a high-volume pancreatic centre.

Shakir M, Boone BA, Polanco PM, Zenati MS, Hogg ME, Tsung A, Choudry HA, Moser AJ, Bartlett DL, Zeh HJ, Zureikat AH.

HPB (Oxford). 2015 Jul;17(7):580-6. doi: 10.1111/hpb.12412. Epub 2015 Apr 23.

22.

Mitogen-activated protein kinase inhibition reduces mucin 2 production and mucinous tumor growth.

Dilly AK, Song X, Zeh HJ, Guo ZS, Lee YJ, Bartlett DL, Choudry HA.

Transl Res. 2015 Oct;166(4):344-54. doi: 10.1016/j.trsl.2015.03.004. Epub 2015 Mar 28.

PMID:
25890193
23.

Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies.

Polanco PM, Ding Y, Knox JM, Ramalingam L, Jones H, Hogg ME, Zureikat AH, Holtzman MP, Pingpank J, Ahrendt S, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2015 May;22(5):1673-9. doi: 10.1245/s10434-014-4111-x. Epub 2014 Nov 7.

PMID:
25377640
24.

A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.

Downs-Canner S, Ding Y, Magge DR, Jones H, Ramalingam L, Zureikat A, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2015 May;22(5):1651-7. doi: 10.1245/s10434-014-4186-4. Epub 2014 Oct 28.

25.

Preoperative inflammatory biomarkers and neurovegetative symptoms in peritoneal carcinomatosis patients.

Low CA, Bovbjerg DH, Jenkins FJ, Ahrendt SA, Choudry HA, Holtzman MP, Jones HL, Pingpank JF, Ramalingam L, Zeh HJ, Zureikat AH, Bartlett DL.

Brain Behav Immun. 2014 Nov;42:65-8. doi: 10.1016/j.bbi.2014.06.019. Epub 2014 Jul 6.

26.

GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival.

Singhi AD, Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Mantha G, Nikiforova M, Bartlett DL, Pai RK.

Hum Pathol. 2014 Aug;45(8):1737-43. doi: 10.1016/j.humpath.2014.04.018. Epub 2014 May 8.

PMID:
24925222
27.

Does obesity affect outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for disseminated mucinous appendiceal neoplasms?

Polanco PM, Sanchez AI, Ramalingam L, Jones H, Zureikat A, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2014 Nov;21(12):3963-9. doi: 10.1245/s10434-014-3807-2. Epub 2014 Jun 11.

PMID:
24916747
28.

Rapamycin-enhanced mitomycin C-induced apoptotic death is mediated through the S6K1-Bad-Bak pathway in peritoneal carcinomatosis.

Song X, Dilly AK, Kim SY, Choudry HA, Lee YJ.

Cell Death Dis. 2014 Jun 5;5:e1281. doi: 10.1038/cddis.2014.242.

29.

Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade.

Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Zhu B, Nikiforova M, Bartlett DL, Pai RK.

Mod Pathol. 2014 Nov;27(11):1521-39. doi: 10.1038/modpathol.2014.37. Epub 2014 Mar 14.

30.

Loss of SMAD4 protein expression is associated with high tumor grade and poor prognosis in disseminated appendiceal mucinous neoplasms.

Davison JM, Hartman DA, Singhi AD, Choudry HA, Ahrendt SA, Zureikat AH, Ramalingam L, Nikiforova M, Pai RK.

Am J Surg Pathol. 2014 May;38(5):583-92. doi: 10.1097/PAS.0000000000000194.

PMID:
24618609
31.

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis.

Magge D, Zenati MS, Austin F, Mavanur A, Sathaiah M, Ramalingam L, Jones H, Zureikat AH, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2014 Apr;21(4):1159-65. doi: 10.1245/s10434-013-3358-y. Epub 2013 Dec 10.

32.

Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin.

Winer J, Zenati M, Ramalingam L, Jones H, Zureikat A, Holtzman M, Lee K, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2014 May;21(5):1456-62. doi: 10.1245/s10434-013-3328-4. Epub 2013 Nov 8.

PMID:
24201745
33.

Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis.

Magge D, Zenati M, Mavanur A, Winer J, Ramalingam L, Jones H, Zureikat A, Holtzman M, Lee K, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2014 May;21(5):1448-55. doi: 10.1245/s10434-013-3327-5. Epub 2013 Nov 7.

34.

Outcome analysis of a decade-long experience of isolated hepatic perfusion for unresectable liver metastases at a single institution.

Magge D, Choudry HA, Zeh HJ 3rd, Cunningham DE, Steel J, Holtzman MP, Jones HL, Pingpank JF, Bartlett DL, Zureikat AH.

Ann Surg. 2014 May;259(5):953-9. doi: 10.1097/SLA.0000000000000261.

PMID:
24169176
35.

A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases from colorectal cancer.

Magge D, Zureikat AH, Bartlett DL, Holtzman MP, Choudry HA, Beumer JH, Pingpank JF, Holleran JL, Strychor S, Cunningham DE, Jones HL, Zeh HJ 3rd.

Ann Surg Oncol. 2013 Jul;20(7):2180-7. doi: 10.1245/s10434-013-2960-3. Epub 2013 Apr 11.

36.

Extensive cytoreductive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival.

Wagner PL, Austin F, Maduekwe U, Mavanur A, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2013 Apr;20(4):1056-62. doi: 10.1245/s10434-012-2791-7. Epub 2013 Mar 2.

37.

Aggressive locoregional management of recurrent peritoneal sarcomatosis.

Baumgartner JM, Ahrendt SA, Pingpank JF, Holtzman MP, Ramalingam L, Jones HL, Zureikat AH, Zeh HJ 3rd, Bartlett DL, Choudry HA.

J Surg Oncol. 2013 Mar;107(4):329-34. doi: 10.1002/jso.23232. Epub 2013 Feb 5.

PMID:
23386388
38.

Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin.

Wagner PL, Austin F, Sathaiah M, Magge D, Maduekwe U, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ 3rd, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2013 Feb;20(2):506-14. doi: 10.1245/s10434-012-2627-5. Epub 2012 Sep 1.

39.

Mucin as a therapeutic target in pseudomyxoma peritonei.

Choudry HA, O'Malley ME, Guo ZS, Zeh HJ, Bartlett DL.

J Surg Oncol. 2012 Dec;106(7):911-7. doi: 10.1002/jso.23146. Epub 2012 May 14. Review.

PMID:
22585683
40.

Critical role of hyperthermic intraperitoneal chemoperfusion in the treatment of a patient with Pseudomyxoma peritonei.

Cole KL, Choudry HA, Jones HL, Goodell PP, Bartlett DL.

J Surg Oncol. 2012 Sep 15;106(4):513-6. doi: 10.1002/jso.23088. Epub 2012 Mar 6.

PMID:
22396067
41.

Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei.

Choudry HA, Mavanur A, O'Malley ME, Zeh HJ, Guo Z, Bartlett DL.

Ann Surg Oncol. 2012 May;19(5):1402-9. doi: 10.1245/s10434-012-2242-5.

42.

Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms.

Austin F, Mavanur A, Sathaiah M, Steel J, Lenzner D, Ramalingam L, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2012 May;19(5):1386-93. doi: 10.1245/s10434-012-2241-6.

43.

Diagnosis and management of retroperitoneal ancient schwannomas.

Choudry HA, Nikfarjam M, Liang JJ, Kimchi ET, Conter R, Gusani NJ, Staveley-O'Carroll KF.

World J Surg Oncol. 2009 Feb 2;7:12. doi: 10.1186/1477-7819-7-12.

44.

Stimulation of expression of the intestinal glutamine transporter ATB0 in tumor-bearing rats.

Choudry HA, Souba WW, Lin C, Meng Q, Karinch AM, Huang J, Pan M.

Ann Surg Oncol. 2006 Dec;13(12):1747-53. Epub 2006 Sep 28.

PMID:
17006743
45.

Branched-chain amino acid-enriched nutritional support in surgical and cancer patients.

Choudry HA, Pan M, Karinch AM, Souba WW.

J Nutr. 2006 Jan;136(1 Suppl):314S-8S. doi: 10.1093/jn/136.1.314S. Review.

PMID:
16365105
46.

Regulation of amino acid arginine transport by lipopolysaccharide and nitric oxide in intestinal epithelial IEC-6 cells.

Meng Q, Choudry HA, Souba WW, Karinch AM, Huang J, Lin C, Vary TC, Pan M.

J Gastrointest Surg. 2005 Dec;9(9):1276-85; discussion 1285.

PMID:
16332483
47.

Arginine transport in catabolic disease states.

Pan M, Choudry HA, Epler MJ, Meng Q, Karinch A, Lin C, Souba W.

J Nutr. 2004 Oct;134(10 Suppl):2826S-2829S; discussion 2853S. doi: 10.1093/jn/134.10.2826S. Review.

PMID:
15465794
48.

Stimulation of intestinal glutamine absorption in chronic metabolic acidosis.

Pan M, Meng Q, Choudry HA, Karinch AM, Lin C, Souba WW.

Surgery. 2004 Aug;136(2):127-34.

PMID:
15300171

Supplemental Content

Loading ...
Support Center